Repeated introductions and intensive community transmission fueled a mumps virus outbreak in Washington State

  1. Louise Hillier Moncla  Is a corresponding author
  2. Allison Black
  3. Chase DeBolt
  4. Misty Lang
  5. Nicholas R Graff
  6. Ailyn C Pérez-Osorio
  7. Nicola F Müller
  8. Dirk Haselow
  9. Scott Lindquist
  10. Trevor Bedford  Is a corresponding author
  1. Fred Hutchinson Cancer Research Center, United States
  2. University of Washington, United States
  3. Washington State Department of Health, United States
  4. Arkansas Department of Health, United States

Abstract

In 2016/2017, Washington State experienced a mumps outbreak despite high childhood vaccination rates, with cases more frequently detected among school-aged children and members of the Marshallese community. We sequenced 166 mumps virus genomes collected in Washington and other US states, and traced mumps introductions and transmission within Washington. We uncover that mumps was introduced into Washington approximately 13 times, primarily from Arkansas, sparking multiple co-circulating transmission chains. Although age and vaccination status may have impacted transmission, our dataset could not quantify their precise effects. Instead, the outbreak in Washington was overwhelmingly sustained by transmission within the Marshallese community. Our findings underscore the utility of genomic data to clarify epidemiologic factors driving transmission, and pinpoint contact networks as critical for mumps transmission. These results imply that contact structures and historic disparities may leave populations at increased risk for respiratory virus disease even when a vaccine is effective and widely used.

Data availability

All code used to analyze data, input files for BEAST, and all code used to generate figures for this manuscript are publicly available at https://github.com/blab/mumps-wa-phylodynamics. Raw FASTQ files with human reads removed are available under SRA project number PRJNA641715. All protocols for generating sequence data as well as the consensus genomes are available at https://github.com/blab/mumps-seq. Consensus genomes have also been deposited to Genbank under accessions MT859507-MT859672.

The following data sets were generated

Article and author information

Author details

  1. Louise Hillier Moncla

    Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, SEATTLE, United States
    For correspondence
    lhmoncla@gmail.com
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5722-1988
  2. Allison Black

    University of Washington, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Chase DeBolt

    Office of Communicable Disease Epidemiology, Washington State Department of Health, Shoreline, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Misty Lang

    Office of Communicable Disease Epidemiology, Washington State Department of Health, Shorelinee, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Nicholas R Graff

    Office of Communicable Disease Epidemiology, Washington State Department of Health, Shoreline, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Ailyn C Pérez-Osorio

    Office of Communicable Disease Epidemiology, Washington State Department of Health, Shoreline, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Nicola F Müller

    Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, SEATTLE, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Dirk Haselow

    Epidemiology, Arkansas Department of Health, Little Rock, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Scott Lindquist

    Office of Communicable Disease Epidemiology, Washington State Department of Health, Shoreline, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Trevor Bedford

    Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, United States
    For correspondence
    tbedford@fredhutch.org
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4039-5794

Funding

National Science Foundation (DGE-1256082)

  • Allison Black

Life Sciences Research Foundation

  • Louise Hillier Moncla

National Institutes of Health (R35 GM119774-01)

  • Trevor Bedford

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.

Metrics

  • 1,320
    views
  • 161
    downloads
  • 15
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Louise Hillier Moncla
  2. Allison Black
  3. Chase DeBolt
  4. Misty Lang
  5. Nicholas R Graff
  6. Ailyn C Pérez-Osorio
  7. Nicola F Müller
  8. Dirk Haselow
  9. Scott Lindquist
  10. Trevor Bedford
(2021)
Repeated introductions and intensive community transmission fueled a mumps virus outbreak in Washington State
eLife 10:e66448.
https://doi.org/10.7554/eLife.66448

Share this article

https://doi.org/10.7554/eLife.66448

Further reading

    1. Microbiology and Infectious Disease
    Srinivasan Vijay, Nguyen Le Hoai Bao ... Nguyen Thuy Thuong
    Research Article

    Antibiotic tolerance in Mycobacterium tuberculosis reduces bacterial killing, worsens treatment outcomes, and contributes to resistance. We studied rifampicin tolerance in isolates with or without isoniazid resistance (IR). Using a minimum duration of killing assay, we measured rifampicin survival in isoniazid-susceptible (IS, n=119) and resistant (IR, n=84) isolates, correlating tolerance with bacterial growth, rifampicin minimum inhibitory concentrations (MICs), and isoniazid-resistant mutations. Longitudinal IR isolates were analyzed for changes in rifampicin tolerance and genetic variant emergence. The median time for rifampicin to reduce the bacterial population by 90% (MDK90) increased from 1.23 days (IS) and 1.31 days (IR) to 2.55 days (IS) and 1.98 days (IR) over 15–60 days of incubation, indicating fast and slow-growing tolerant sub-populations. A 6 log10-fold survival fraction classified tolerance as low, medium, or high, showing that IR is linked to increased tolerance and faster growth (OR = 2.68 for low vs. medium, OR = 4.42 for low vs. high, p-trend = 0.0003). High tolerance in IR isolates was associated with rifampicin treatment in patients and genetic microvariants. These findings suggest that IR tuberculosis should be assessed for high rifampicin tolerance to optimize treatment and prevent the development of multi-drug-resistant tuberculosis.

    1. Evolutionary Biology
    2. Microbiology and Infectious Disease
    Zachary H Williams, Alvaro Dafonte Imedio ... Welkin E Johnson
    Research Article Updated

    HERV-K(HML-2), the youngest clade of human endogenous retroviruses (HERVs), includes many intact or nearly intact proviruses, but no replication competent HML-2 proviruses have been identified in humans. HML-2-related proviruses are present in other primates, including rhesus macaques, but the extent and timing of HML-2 activity in macaques remains unclear. We have identified 145 HML-2-like proviruses in rhesus macaques, including a clade of young, rhesus-specific insertions. Age estimates, intact open reading frames, and insertional polymorphism of these insertions are consistent with recent or ongoing infectious activity in macaques. 106 of the proviruses form a clade characterized by an ~750 bp sequence between env and the 3′ long terminal repeat (LTR), derived from an ancient recombination with a HERV-K(HML-8)-related virus. This clade is found in Old World monkeys (OWM), but not great apes, suggesting it originated after the ape/OWM split. We identified similar proviruses in white-cheeked gibbons; the gibbon insertions cluster within the OWM recombinant clade, suggesting interspecies transmission from OWM to gibbons. The LTRs of the youngest proviruses have deletions in U3, which disrupt the Rec Response Element (RcRE), required for nuclear export of unspliced viral RNA. We show that the HML-8-derived region functions as a Rec-independent constitutive transport element (CTE), indicating the ancestral Rec–RcRE export system was replaced by a CTE mechanism.